IL6 and colorectal carcinoma: Likewise, TAMs conditioned by CRC notably elevate IL-6 secretion, activating the Jak2/STAT3 pathway and indirectly boosting forkhead box Q1 (FoxQ1) expression in cancer, thus reinforcing EMT and cancer stem cell attributes (Wei et al., 2019a).